Loading clinical trials...

Inhaled Ibuprofen to Treat COVID-19 | Clinical Trials | Clareo Health

UNKNOWNNANCT04382768

Inhaled Ibuprofen to Treat COVID-19

The study aims to evaluate the reduction in severity and progression of lung injury with inhaled ibuprofen in patients with severe acute respiratory syndrome due to SARS-CoV-2 virus.

Lead sponsor: Química Luar SRL•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Dante M Beltramo, PhD

CONTACT

54 9 351 766-8050 dantemiguelbeltramo@gmail.com

Nestor H García, MD, PhD

CONTACT

5493513539948 garcia.nestor@conicet.gov.ar

Related studies

RECRUITINGNA

Positioning of Children With Acute Respiratory Insufficiency

NCT07170085 · Acute Respiratory Disease

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITING

Belgian Lung Function Study

NCT07419555 · Chronic Respiratory Diseases

RECRUITINGNA

A New Portable Device for Non-invasive Ventilatory Support

NCT06716502 · Healthy, Respiratory Disease

RECRUITING

Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics

NCT06796894 · Asthma, Respiratory Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 11, 2020Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment40

Start dateMay 2020

Last updatedJun 11, 2020

Condition

Coronavirus Infection Respiratory Disease SARS (Disease)

Locations shown

Centro de Excelencia en Productos y Procesos Córdoba

Córdoba

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 11, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions